GSK547
- CAS NO.:2226735-55-1
- Empirical Formula: C20H18F2N6O
- Molecular Weight: 396.39
- MDL number: MFCD32062767
- Update Date: 2026-03-13 23:13:44
What is GSK547?
Biological Activity
GSK'547 is a highly selective and potent inhibitor of RIP1 (RIPK1) with a 400-fold increase in oral exposure compared to GSK'963 in mouse pharmacokinetic studies.
in vitro
In vitro, treatment with GSK'547 directed bone marrow-derived macrophages to develop an immunogenic phenotype, with up-regulation of MHC-II, TNFa and IFNg expression, and decreased CD206, IL- 10 and TGFb expression. In addition, it also up-regulated STAT1 signaling and decreased STAT3, STAT5 and STAT6 signaling in bone marrow-derived macrophages. Macrophages treated with GSK'547 had stronger ability to capture antigens.
in vivo
Mice were given GSK'547 through food, the concentration of GSK'547 in vivo was stable within 24 hours, which was higher than the IC50 value in L929 cells. GSK'547 maintained high concentrations in vivo during the 6-week administration. GSK'547 was well tolerated with no obvious pathological features. In mice with in situ pancreatic ductal adenocarcinoma, It reduced tumor burden and prolonged survival compared to control and Nec-1s-treated groups. GSK'547 prevents established tumors and liver metastases.
Properties of GSK547
| Boiling point: | 578.3±60.0 °C(Predicted) |
| Density | 1.43±0.1 g/cm3(Predicted) |
| storage temp. | Store at -20°C |
| solubility | DMSO:65.0(Max Conc. mg/mL);163.98(Max Conc. mM) |
| form | Solid |
| pka | 1.93±0.28(Predicted) |
| color | White to off-white |
Safety information for GSK547
| Signal word | Warning |
| Pictogram(s) |
![]() Exclamation Mark Irritant GHS07 |
| GHS Hazard Statements |
H302:Acute toxicity,oral H315:Skin corrosion/irritation H319:Serious eye damage/eye irritation H335:Specific target organ toxicity, single exposure;Respiratory tract irritation |
| Precautionary Statement Codes |
P261:Avoid breathing dust/fume/gas/mist/vapours/spray. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing. |
Computed Descriptors for GSK547
New Products
Methyl N-((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)-N-nitroso-L-valinate Levofloxacin - Impurity B/ Levofloxacin Related Compound A Ivabradine R isomer Escitalopram - Impurity K Escitalopram Cyno dilol Impurity Paroxetine EP impurity I/Paroxetine Anhydrous EP Impurity I 2-Amino-5-Bromo-6-Chloropyridine 3-Amino-5-bromopicolinic acid 1-(7,8-Dinitro-4,5-dihydro-1H-1,5-methanobenzo[d]azepin-3(2H)-yl)-2,2,2-trifluoroethanone 2-Amino-3-Bromo-5-Cyanopyridine 2-Amino-3-Chloropyridine 2,5-Dibromo-3-MethylpyridineRelated products of tetrahydrofuran

![4-Chloro-N-[2-[[5-(trifluoromethyl)-2-pyridinyl]sulfonyl]ethyl]benzamide](https://img.chemicalbook.in/CAS/GIF/188591-46-0.gif)






You may like
-
17471-10-2 Diphenhydramine EP impurity-A /Diphenhydramine Related Compound A NLT 95%View Details
17471-10-2 -
Dorzolamide Related Compound B/Dorzolamide EP Impurity B NLT 95%View Details
120279-90-5 -
76824-16-3 Famotidine - Impurity D NLT 95%View Details
76824-16-3 -
Metoprolol Impurity T NLT 95%View Details
73723-85-0 -
118-23-0 NLT 95%View Details
118-23-0 -
Miconazole EP Impurity F/ Miconazole USP Related Compound F 47447-55-2 NLT 95%View Details
47447-55-2 -
2407630-84-4 NLT 95%View Details
2407630-84-4 -
573704-41-3 NLT 95%View Details
573704-41-3

